MD2-TLR4-IN-1 |
| Katalog-Nr.GC36578 |
MD2-TLR4-IN-1 (Verbindung 22m) ist ein Inhibitor des myeloiden Differenzierungsprotein 2/Toll-like-Rezeptor 4 (MD2-TLR4)-Komplexes, der die durch Lipopolysaccharide (LPS) induzierte Expression des Tumornekrosefaktors alpha (TNF-α) hemmt. und Interleukin-6 (IL-6) in Makrophagen mit IC50-Werten von 0,89 μM bzw. 0,53 μM.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2249801-12-3
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
MD2-TLR4-IN-1 (compound 22m) is an inhibitor of myeloid differentiation protein 2/toll-like receptor 4 (MD2-TLR4) complex, inhibiting lipopolysaccharides (LPS)-induced expression of tumor necrosis factor alpha (TNF-α) and interleukin-6 (IL-6) in macrophages with IC50 values of 0.89 μM and 0.53 μM, respectively[1]. MD2-TLR4[1].
[1]. Liu Z, et al. Discovery of 3-(Indol-5-yl)-indazole Derivatives as Novel Myeloid Differentiation Protein 2/Toll-like Receptor 4 Antagonists for Treatment of Acute Lung Injury. J Med Chem. 2019 Jun 13;62(11):5453-5469.
Average Rating: 5 (Based on Reviews and 18 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *